TMCI

#3862
Treace Medical Concepts, Inc. Common Stock
2.13 USD
+5.97%
セクター: ヘルスケア
ベース: USD
利益通貨: USD
日中レンジ
2.13
2.13
1年のレンジ
1.17
7.78
1日の変化
+5.97%
月次変化
+43.92%
6か月変化
-65.65%
1年の変化
-67.73%
以前の終値
2.01
始値
2.13
Bid
Ask
安値
2.13
High
2.13
ボリューム
66
チャート全体を表示

Financials

概要 明細書 統計
期次 年次
  • Market Capitalization 137.58 M
  • Employee 450
  • Founded 2014
  • CEO N/A
  • Website www.treace.com
  • Headquarter Florida, United States
  • FIGI BBG00GQKR6M4
  • Industry Technology
総売上高
当期純利益
1株当たり基本利益（基本EPS）
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-2.63
売上高対価格比率
0.73

Treace Medical Concepts Inc

Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions. In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021.

ニュース